neuroendocrine


Also found in: Medical, Encyclopedia, Wikipedia.

neu·ro·en·do·crine

 (no͝or′ō-ĕn′də-krĭn, -krēn′, -krīn′, nyo͝or′-)
adj.
Of, relating to, or involving the interaction between the nervous system and the hormones of the endocrine glands: the neuroendocrine apparatus in birds.

neuroendocrine

(ˌnjʊərəʊˈɛndəʊˌkraɪn)
adj
(Physiology) of, relating to, or denoting the dual control of certain body functions by both nervous and hormonal stimulation: neuroendocrine system.

neu•ro•en•do•crine

(ˌnʊər oʊˈɛn də krɪn, -ˌkraɪn, -ˌkrin, ˌnyʊər-)

adj.
of or pertaining to the interactions between the nervous and endocrine systems, esp. in relation to hormones.
[1920–25]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.neuroendocrine - of or relating to the nervous and endocrine systems (especially as they function together)
Mentioned in ?
References in periodicals archive ?
16 (ANI): Finally breaking his silence, Irrfan Khan revelaed that he is diagnosed with NeuroEndocrine Tumour.
Actor Irrfan Khan has confirmed he has been diagnosed with a neuroendocrine tumour, which is described as a rare condition that develops from cells of the endocrine (hormonal) system that are found in organs including the stomach, bowel and lungs.
The US Food and Drug Administration (FDA) has approved France-based Advanced Accelerator Applications' radioactive drug, Lutathera (lutetium Lu 177 dotatate), intended for the treatment of gastroenteropancreatic neuroendocrine tumours, it was reported yesterday.
has received US Food and Drug Administration approval of its new drug application for Lutathera for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors, including foregut, midgut, and hindgut neuroendocrine tumors, in adults.
Primary neuroendocrine tumors (NETs) of the breast are a unique but rare subtype of breast cancer.
Neuroendocrine markers (chromogranin and synaptophysin) were performed on 25 and 6 cases, from which it showed weak positivity in 3 cases.
Ipsen and Teijin Pharma Limited, the core company of the Teijin Groups healthcare business, today announced that Teijin Pharma has received approval from the Japanese Ministry of Health, Labour and Welfare for Ipsens subcutaneous drug Somatuline (lanreotide) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP NET).
Neuroendocrine tumors (NETs) develop from cells of the neuroendocrine system.
Ultrasound-guided biopsy of the right breast mass revealed high-grade neuroendocrine tumor with small cell features; ER/PR negative, Her-2 negative and Ki-67 positive at 99%.
This patient has a non-PSA-producing carcinoma of the prostate, called neuroendocrine prostate cancer (NEPC), that develops from neuroendocrine cells of the prostate.
Global Markets Direct's, 'Neuroendocrine Tumors - Pipeline Review, H1 2016', provides an overview of the Neuroendocrine Tumors pipeline landscape.